Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Bull Exp Biol Med ; 149(6): 727-30, 2010 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21165431

RESUMEN

Lyticase (a bacterial enzyme) was tested as a new antimycotic drug. Of all objects studied, Cellulomonas cellulans AC-870 strain proved to be most productive for this enzyme. A technology for lyticase isolation and purification was proposed. An experimental model of recurrent vaginal candidiasis was created. The model includes combined antibiotic and estradiol therapy. Antimycotic effect of lyticase on the model of recurrent vaginal candidiasis in mice was demonstrated.


Asunto(s)
Candidiasis Vulvovaginal/tratamiento farmacológico , Glucano Endo-1,3-beta-D-Glucosidasa/metabolismo , Complejos Multienzimáticos/metabolismo , Péptido Hidrolasas/metabolismo , Animales , Femenino , Glucano Endo-1,3-beta-D-Glucosidasa/uso terapéutico , Ratones , Complejos Multienzimáticos/uso terapéutico , Péptido Hidrolasas/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA